2023
The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank
Li F, Ramirez Y, Yano Y, Daniel C, Sharma S, Brown E, Li R, Moshiree B, Loftfield E, Lan Q, Sinha R, Inoue-Choi M, Vogtmann E. The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank. Annals Of Epidemiology 2023, 88: 15-22. PMID: 38013230, PMCID: PMC10842122, DOI: 10.1016/j.annepidem.2023.10.008.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseCause-specific mortalityBody mass indexColorectal cancerCause mortalityHazard ratioBowel diseaseMortality rateMultivariable Cox proportional hazards regression modelsHistory of IBDCox proportional hazards regression modelProportional hazards regression modelsBreast cancer mortality ratesProspective cohort studyCRC mortality ratesRisk of deathHazards regression modelsRisk of mortalityConfidence intervalsHospital admission dataPatient management strategiesCancer mortality ratesUK BiobankIBD diagnosisCohort study
2022
Association Between Center Level Characteristics And 1-Month Post-LVAD Implant Risk Standardized Mortality Rates
Hendren N, Peltz M, Khera R, Koch S, Young J, Starling R, Tang W, Pandey A, Drazner M, Grodin J. Association Between Center Level Characteristics And 1-Month Post-LVAD Implant Risk Standardized Mortality Rates. Journal Of Cardiac Failure 2022, 28: s59. DOI: 10.1016/j.cardfail.2022.03.151.Peer-Reviewed Original ResearchRisk standardized mortality ratesCenter-level characteristicsPatient-level characteristicsStandardized mortality rateMortality rateConcomitant mitral valve repairMultivariable logistic regression modelCardiopulmonary bypass timeDurable continuous flowPost-LVAD outcomesPercentage of patientsTotal surgical timeMitral valve repairPatient management strategiesPost-implantation outcomesVentricular assist deviceCochran-Armitage trendChi-square testLogistic regression modelsIABP removalIntraoperative ECMOBypass timeCF-LVADsValve repairDestination therapy
2010
Review: Castration-resistant prostate cancer: new science and therapeutic prospects
Bellmunt J, Oh W. Review: Castration-resistant prostate cancer: new science and therapeutic prospects. Therapeutic Advances In Medical Oncology 2010, 2: 189-207. PMID: 21789134, PMCID: PMC3126017, DOI: 10.1177/1758834009359769.Peer-Reviewed Original ResearchCastration-resistant prostate cancerAndrogen receptorCastration-resistant prostate cancer treatmentTherapies targeting different pathwaysGonadotropin-releasing hormone therapyCastration-resistant prostate cancer tissuesLigand-activated androgen receptorAgents targeting angiogenesisImprove patient selectionLate-stage clinical testingManagement of patientsClinical trial optionsPatient management strategiesMDV-3100Sipuleucel-THormone therapyProstate cancerPatient selectionOral compoundsPatient populationAndrogen levelsPatientsClinical testingTrial optionsTrial design
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply